Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed) | RFA AR 24 003

Opportunity Information: Apply for RFA AR 24 003

The Core Centers for Clinical Research (CCCR) funding opportunity (RFA-AR-24-003) is a National Institutes of Health (NIH) discretionary grant that uses the P30 center core grant mechanism to support shared research infrastructure for clinical research programs. As a P30, the emphasis is on building and sustaining centralized resources (cores), services, and administrative coordination that multiple investigators can use to strengthen, streamline, and expand clinical research capacity in the relevant scientific area. The notice is explicitly labeled "Clinical Trial Not Allowed," meaning applicants should not propose independent clinical trials as part of the award. In practice, this type of opportunity is designed to underwrite the core capabilities that make high-quality clinical research possible (for example, shared clinical research support, data management, regulatory support, biostatistics, and other cross-cutting resources), rather than paying for the conduct of a clinical trial itself.

The opportunity falls under the Health funding activity category and is associated with CFDA number 93.846. The agency is NIH, and the original closing date listed is 2023-09-12. The award ceiling shown is $500,000, indicating an upper bound on the amount that can be requested or awarded (as presented in the source data), and applicants would typically be expected to propose a budget that aligns with the scope of the cores and the number of investigators served. The listing does not provide an expected number of awards in the provided excerpt, so the competitive landscape and likely funding volume would need to be inferred from the full announcement or NIH institute budget context.

A broad range of applicant organizations are eligible. Standard eligible applicant types include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories as specified); for-profit organizations other than small businesses; small businesses; and a general "others" category that NIH uses to capture additional eligible organizational types. The announcement also highlights additional eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and tribal governments that are not federally recognized. U.S. territories or possessions are also explicitly included as eligible.

Restrictions related to foreign involvement are spelled out. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. At the same time, "foreign components" are allowed as defined by the NIH Grants Policy Statement, which generally means a U.S.-based applicant can include certain elements of the project being carried out by a foreign entity or at a foreign site when well-justified and compliant with NIH policy. This distinction matters because it preserves the ability to collaborate internationally or access unique populations/resources when appropriate, while keeping the applicant organization domestic and ensuring NIH oversight and policy requirements are met.

Overall, this CCCR P30 opportunity is best understood as an NIH center infrastructure award aimed at improving the efficiency, quality, and reach of clinical research by funding shared cores and centralized support. It is not intended to directly fund the execution of clinical trials, but rather to provide the backbone resources that enable multiple investigators and projects to operate more effectively within a coordinated clinical research environment.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
• This funding opportunity was created on 2023-04-06.
• Applicants must submit their applications by 2023-09-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AR 24 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: